DMT Models the Near-Death Experience

Frontiers in Psychology
Christopher TimmermannR L Carhart-Harris

Abstract

Near-death experiences (NDEs) are complex subjective experiences, which have been previously associated with the psychedelic experience and more specifically with the experience induced by the potent serotonergic, N,N-Dimethyltryptamine (DMT). Potential similarities between both subjective states have been noted previously, including the subjective feeling of transcending one's body and entering an alternative realm, perceiving and communicating with sentient 'entities' and themes related to death and dying. In this within-subjects placebo-controled study we aimed to test the similarities between the DMT state and NDEs, by administering DMT and placebo to 13 healthy participants, who then completed a validated and widely used measure of NDEs. Results revealed significant increases in phenomenological features associated with the NDE, following DMT administration compared to placebo. Also, we found significant relationships between the NDE scores and DMT-induced ego-dissolution and mystical-type experiences, as well as a significant association between NDE scores and baseline trait 'absorption' and delusional ideation measured at baseline. Furthermore, we found a significant overlap in nearly all of the NDE phenomenological feat...Continue Reading

References

Jun 1, 1983·The Journal of Nervous and Mental Disease·B Greyson
Jan 1, 1980·Psychiatry·R Noyes
Mar 1, 1993·The Journal of Nervous and Mental Disease·A Kellehear
Jul 10, 2003·General Hospital Psychiatry·Bruce Greyson
Mar 1, 1959·The Journal of Genetic Psychology·A H MASLOW
Jul 1, 1959·A.M.A. Archives of General Psychiatry·A F WALLACE
Mar 27, 2004·Psychological Science·Willoughby B Britton, Richard R Bootzin
Jun 15, 2005·Schizophrenia Bulletin·Emmanuelle PetersPhilippa Garety
Jun 21, 2005·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Ulrich OttDieter Vaitl
Jul 3, 2008·Journal of Psychopharmacology·Mw JohnsonRr Griffiths
Sep 8, 2010·Archives of General Psychiatry·Charles S GrobGeorge R Greer
Sep 9, 2010·PloS One·Erich StuderusFranz X Vollenweider
Jun 16, 2011·Psychopharmacology·Roland R GriffithsRobert Jesse
Oct 1, 2011·Journal of Psychopharmacology·Katherine A MacLeanRoland R Griffiths
Mar 1, 2012·PloS One·Erich StuderusFranz X Vollenweider
Aug 14, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jimo BorjiginGeorge A Mashour
Oct 8, 2013·Frontiers in Human Neuroscience·Claire Petitmengin, Jean-Philippe Lachaux
Apr 29, 2014·Frontiers in Psychology·Robin Carhart-Harris, David Nutt
Jul 6, 2014·Human Brain Mapping·Enzo TagliazucchiDante R Chialvo
Sep 13, 2014·Journal of Psychopharmacology·Matthew W JohnsonRoland R Griffiths
Sep 23, 2014·Psychopharmacology·R L Carhart-HarrisD J Nutt
Oct 9, 2014·Annual Review of Psychology·Jonathan Smallwood, Jonathan W Schooler
Jan 8, 2015·Current Drug Abuse Reviews·Albert Garcia-RomeuMatthew W Johnson
Jan 15, 2015·Journal of Psychopharmacology·Michael P BogenschutzRick J Strassman
Mar 19, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Michael P Bogenschutz, Matthew W Johnson
Mar 26, 2015·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Flávia de L OsórioJaime E Hallak
Mar 31, 2015·The International Journal of Neuropsychopharmacology·Joan Francesc AlonsoJordi Riba
Oct 8, 2015·Journal of Psychopharmacology·Frederick S BarrettRoland R Griffiths
Feb 5, 2016·Pharmacological Reviews·David E Nichols
Apr 14, 2016·Proceedings of the National Academy of Sciences of the United States of America·Robin L Carhart-HarrisDavid J Nutt
Apr 17, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Mendel KaelenRobin Carhart-Harris
May 24, 2016·The Lancet. Psychiatry·Robin L Carhart-HarrisDavid J Nutt
Jul 6, 2016·Frontiers in Human Neuroscience·Matthew M NourRobin L Carhart-Harris
Apr 27, 2017·Journal of Psychoactive Drugs·Matthew M NourRobin L Carhart-Harris
Jun 21, 2017·Journal of Psychopharmacology·Matthias Forstmann, Christina Sagioglou

❮ Previous
Next ❯

Citations

Jun 22, 2019·Pharmacological Reviews·R L Carhart-Harris, K J Friston
Feb 14, 2020·Perspectives on Psychological Science : a Journal of the Association for Psychological Science·Ann Taves
Nov 21, 2019·Scientific Reports·Christopher TimmermannRobin L Carhart-Harris
Mar 8, 2019·Neuroscience of Consciousness·H CassolC Martial
Jul 29, 2019·Current Neurology and Neuroscience Reports·Costanza PeinkhoferDaniel Kondziella
Aug 15, 2020·Frontiers in Neurology·Daniel Kondziella
Nov 12, 2020·Journal of Psychopharmacology·Ari Brouwer, Robin Lester Carhart-Harris
Nov 24, 2020·Consciousness and Cognition·Charlotte MartialHéléna Cassol
Feb 12, 2021·Journal of Psychopharmacology·Carla PallaviciniEnzo Tagliazucchi
Dec 22, 2020·Neuroscience of Consciousness·Michael M Schartner, Christopher Timmermann
Mar 13, 2021·Risk Management and Healthcare Policy·Rafael Guimarães Dos SantosJaime E Hallak
Apr 9, 2021·Frontiers in Human Neuroscience·Filippo CieriDietmar Cordes
Jun 16, 2021·Consciousness and Cognition·Tim Julian MöllerLaura Kaltwasser
Jun 18, 2021·Neuroscience and Biobehavioral Reviews·Ruben E Laukkonen, Heleen A Slagter
Aug 6, 2021·Frontiers in Psychiatry·Rita KočárováRobin Carhart-Harris
Jul 10, 2021·Brain Communications·Costanza PeinkhoferDaniel Kondziella
Aug 7, 2021·Brain Sciences·Charlotte MartialHéléna Cassol
Oct 7, 2020·ACS Chemical Neuroscience·Genı S OnaJosé Carlos Bouso
Sep 8, 2021·Frontiers in Psychology·Jessica Sophie Corneille, David Luke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Religion and Health
S A McLaughlin, H N Malony
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Chun-Fu LaiWang-Yu Chen
© 2022 Meta ULC. All rights reserved